Continuous hyperthermic peritoneal perfusion (CHPP) for malignant ascites and irresectable intra-abdominal cancer

MeSH terms

• Abdominal Neoplasms / mortality
• Abdominal Neoplasms / pathology
• Abdominal Neoplasms / therapy*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Ascites / mortality
• Ascites / therapy*
• Cell Division
• Cisplatin / administration & dosage
• Combined Modality Therapy
• Female
• Fluorouracil / administration & dosage
• Humans
• Hyperthermia, Induced*
• Infusions, Parenteral / methods
• Male
• Melphalan / administration & dosage
• Middle Aged
• Mitomycin / administration & dosage
• Perfusion
• Survival Rate